Impax and GSK Announce Positive Topline Results of ASCEND-PD Phase III Study of IPX066 in Advanced Parkinson's Disease - Drugs.com MedNews
Links shared publicly online about this topic.
- 70total visits
Impax and GSK Announce Positive Topline Results of ASCEND-PD Phase III Study of IPX066 in Advanced Parkinson's Disease - Drugs.com MedNews
- IPX066 demonstrated statistically significant improvement over carbidopa-levodopa plus entacapone in reducing the percentage of off time during waking hours A
View full resource at drugs.com
Tags: Parkinson's Disease, Disease and Condition, Drug, GlaxoSmithKline, disease
Most Recently Shared on August 15, 2011 at 4:03 pm By:
Impax and GSK Announce Positive Topline Results of ASCEND-PD Phase III Study of IPX066 in Advanced Parkins... http://t.co/UVzIYCu #drug
Advertisement
